The Human Monoclonal anti-B7-H2 (Prezalumab Biosimilar) antibody has been validated for . It is suitable to detect B7-H2 (Prezalumab Biosimilar) in samples from Human.
Catalog No. ABIN7597924
Quick Overview for Recombinant B7-H2 (Prezalumab Biosimilar) antibody (ABIN7597924)
Target
B7-H2 (Prezalumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Human
Clonality
Monoclonal
Conjugate
This B7-H2 (Prezalumab Biosimilar) antibody is un-conjugated
Application
Please inquire
Grade
Research Grade
Expression System
Mammalian cells
Purpose
Research Grade Prezalumab Biosimilar Antibody
Specificity
B7RP1, B7-related protein 1, CD275, ICOSL, ICOSLG, KIAA0653, B7 homolog 2, ICOS ligand, B7RP-1, B7H2, B7-H2, B7-like protein Gl50
Purification
Protein A or G purified from cell culture supernatant.
Reactivity: Human
FACS, BLI, ELISA, Func, SPR
Host: Human
Monoclonal
unconjugated
Recombinant Antibody
Restrictions
For Research Use only
Format
Liquid
Concentration
3.51 mg/mL
Buffer
0.01M PBS, pH 7.4.
Storage
4 °C,-20 °C,-80 °C
Storage Comment
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
Expiry Date
12 months
Target
B7-H2 (Prezalumab Biosimilar)
Alternative Name
Prezalumab Biosimilar
Target Type
Biosimilar
Background
B7RP1, B7-related protein 1, CD275, ICOSL, ICOSLG, KIAA0653, B7 homolog 2, ICOS ligand, B7RP-1, B7H2, B7-H2, B7-like protein Gl50